First-line zorifertinib for EGFR-mutant non-small cell lung cancer with central nervous system metastases: The phase 3 EVEREST trial
18Citations signalées — pas une note de qualité
58Institutions déclarées
5Pays d’affiliation déclarés
Résumé indisponible : les résultats de l’étude ne doivent pas être déduits depuis son seul titre.
Contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- First-line zorifertinib for EGFR-mutant non-small cell lung cancer with central nervous system metastases: The phase 3 EVEREST trial
- Date Crossref
- 01/01/2025
- Éditeur
- Elsevier BV
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude et ne compte pas comme une seconde source scientifique indépendante.
Institutions déclarées
Guangdong Academy of Medical SciencesGuangdong Provincial People's HospitalSouthern Medical UniversityHarbin Medical UniversityThird Affiliated Hospital of Harbin Medical UniversityShandong Tumor HospitalShandong First Medical UniversityJilin Province Tumor HospitalChongqing UniversityChongqing Cancer HospitalUniversity of Science and Technology of ChinaChinese Academy of SciencesZhejiang Cancer HospitalLinyi People's HospitalFirst Affiliated Hospital of Zhengzhou UniversityJilin UniversityFirst Hospital of Jilin UniversityFirst Affiliated Hospital Zhejiang UniversityNanjing General Hospital of Nanjing Military CommandNanjing UniversityFujian Medical UniversityFujian Provincial Cancer HospitalZhengzhou UniversityHenan Cancer HospitalHubei Cancer HospitalKunming Medical UniversityUnion HospitalHuazhong University of Science and TechnologyJiangsu Cancer HospitalNanjing Medical UniversityShanghai Chest HospitalFirst Affiliated Hospital of Xiamen UniversitySichuan Cancer HospitalXuzhou Medical CollegeArmy Medical UniversityChina Three Gorges UniversityYichang Central People's HospitalTaichung Veterans General HospitalCentral South UniversityHunan Cancer HospitalSun Yat-sen UniversityThe First Affiliated Hospital, Sun Yat-sen UniversityPeking UniversityPeking University Cancer HospitalFirst Affiliated Hospital of Xi'an Jiaotong UniversityTianjin Medical University General HospitalHangzhou Cancer HospitalZhejiang UniversityLinkou Chang Gung Memorial HospitalXinqiao HospitalQingdao UniversityYuhuangding HospitalThe Catholic University of Korea St. Vincent's HospitalTongji HospitalJiangsu T-mab BioPharma (China)Samsung Medical CenterChinese Academy of Medical Sciences & Peking Union Medical CollegeNational Cancer Center
Une affiliation ne permet pas de déduire la nationalité d’un auteur.
Sujets associés
Lung Cancer Treatments and MutationsBrain Metastases and TreatmentLung Cancer Research Studies